OWLT's fourth-quarter results are likely to reflect subscription growth, FDA-backed differentiation and revenue gains, even as tariff pressures weigh on margins.
OWLT is deepening healthcare partnerships to expand adoption beyond consumers, starting with hospital-prescribed monitoring and broader clinical use cases.
Remote and continuous patient monitoring is moving from a niche capability to a core pillar of modern healthcare, driven by aging populations, staffing shortages, and a push toward data-driven care both inside hospitals and at home. Against this backdrop, Owlet, Inc. OWLT and Masimo Corporation MASI represent two very different ways to invest in the same secular trend.
| Health Care Technology Industry | Healthcare Sector | Jonathan Harris CEO | NYSE Exchange | 69120X107 CUSIP |
| US Country | 80 Employees | - Last Dividend | 10 Jul 2023 Last Split | 5 Nov 2020 IPO Date |
Owlet, Inc. is a company dedicated to pioneering digital parenting solutions both in the United States and around the globe. With a focus on providing real-time data and insights to parents, Owlet aims to ease the challenges of parenting through innovative technology. The company's mission revolves around enhancing the safety and well-being of infants by offering a suite of products that monitor vital signs and sleep patterns. Since its inception in 2012, Owlet has established its headquarters in Lehi, Utah, and has become a key player in the realm of infant health monitoring technology.
Owlet’s extensive range of products and services is designed to deliver peace of mind to parents by keeping them informed about their baby’s health and wellness.